Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ENTRADA THERAPEUTICS, INC. (TRDA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ENTRADA THERAPEUTICS, INC. (TRDA), most recent 12 months reported: revenue $4.69M, net loss $165.78M, free cash flow -$134.35M. Latest balance sheet on file: liquid cash $223M. From SEC filings. Others in Pharmaceutical Preparations: NewAmsterdam Pharma Company N.V. · HCW Biologics Inc. · RANI THERAPEUTICS HOLDINGS, INC. · Bolt Biotherapeutics, Inc. · KYNTRA BIO, INC. · Ensysce Biosciences, Inc. · CAMP4 Therapeutics Corporation · CHINA PHARMA HOLDINGS, INC.

Stock screener

Watchlist